Aerosolization of lipoplexes using AERx® pulmonary delivery system
Journal Title: The AAPS Journal - Year 2002, Vol 4, Issue 3
Abstract
The lung represents an attractive target for delivering gene therapy to achieve local and potentially systemic delivery of gene products. The objective of this study was to evaluate the feasibility of the AERx Pulmonary Delivery System for delivering nonviral gene therapy formulations to the lung. We found that “naked” DNA undergoes degradation following aerosolization through the AERx nozzle system. However, DNA formulated with a molar excess of cationic lipids (lipoplexes) showed no loss of integrity. In addition, the lipoplexes showed no significant change in particle size, zeta (ζ) potential, or degree of complexation following extrusion. The data suggest that complexation with cationic lipids had a protective effect on the formulation following extrusion. In addition, there was no significant change in the potency of the formulation as determined by a transfection study in A-549 cells in culture. We also found that DNA formulations prepared in lactose were aerosolized poorly. Significant improvements in aerosolization efficiency were seen when electrolytes such as NaCl were added to the formulation. In conclusion, the data suggest that delivery of lipoplexes using the AERx Pulmonary Delivery System may be a viable approach for pulmonary gene therapy.
Authors and Affiliations
Deepa Deshpande, James Blanchard, Sudarshan Srinivasan, Dallas Fairbanks, Jun Fujimoto, Teiji Sawa, Jeanine Wiener-Kronish, Hans Schreier, Igor Gonda
Keywords
Related Articles
- EP ID EP682003
- DOI 10.1208/ps040313
- Views 119
- Downloads 0
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys
Hemostasis in humans and other animals is a complex process that controls blood loss after a vascular injury. Factor XIII (FXIII) stabilizes clots primarily by cross-linking fibrin, thus protecting a newly formed clot fr...
In Vitro Characterization of a Novel Polymeric System for Preparation of Amorphous Solid Drug Dispersions
The online version of this article (doi:10.1208/s12248-014-9590-y) contains supplementary material, which is available to authorized users.
Interaction of Oxazaphosphorines with Multidrug Resistance-Associated Protein 4 (MRP4)
Multidrug resistance-associated protein 4 (MRP4) is an organic anion efflux pump capable of transporting nucleoside, nucleotide analogs, and cyclic nucleotide. MRP4 could have an influence on the resistance and transport...
High-Throughput screeening assays for CYP2B6 metabolism and inhibition usuing fluorogenic vivid substrates
CYP2B6 is a highly polymorphic P450 isozyme involved in the metabolism of endo-and xenobiotics with known implications for the activation of many procarcinogens resulting in carcinogenesis. However, lack of validated hig...
Delivery of siRNA Therapeutics: Barriers and Carriers
RNA interference is a naturally occurring endogenous regulatory process where short double-stranded RNA causes sequence-specific posttranscriptional gene silencing. Small interference RNA (siRNA) represents a promising t...